Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-023443

Chief Financial Officer sold 5,417 shares at $1.93 ($10,455)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mostafa Adam S. Chief Financial Officer 2023-06-23 Sale −5,417 $1.93 $10,455 82,862 D
Open-market sales · 5,417 sh · avg $1.93 · $10,455
Loading xslF345X04/wk-form4_1687810394.xml…